25th Aug 2021 4:42 pm |
RNS |
Holding(s) in Company |
24th Aug 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
24th Aug 2021 4:36 pm |
RNS |
Price Monitoring Extension |
9th Aug 2021 5:06 pm |
RNS |
Holding(s) in Company |
20th Jul 2021 11:57 am |
RNS |
Holding(s) in Company |
16th Jul 2021 1:50 pm |
RNS |
Holding(s) in Company |
14th Jul 2021 10:23 am |
RNS |
Holding(s) in Company |
13th Jul 2021 5:02 pm |
RNS |
Result of AGM and Business Update |
13th Jul 2021 3:55 pm |
RNS |
Holding(s) in Company |
13th Jul 2021 7:00 am |
RNS |
Early data for SFX-01 in leukaemia cell lines |
13th Jul 2021 7:00 am |
RNS |
Glioma Orphan Drug application submitted to US FDA |
9th Jul 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
9th Jul 2021 11:00 am |
RNS |
Price Monitoring Extension |
9th Jul 2021 7:00 am |
RNS |
Interim Safety and Futility Analysis - STAR trial |
18th Jun 2021 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
15th Jun 2021 7:00 am |
RNS |
Final Results |
14th Jun 2021 7:00 am |
RNS |
Progress on metastatic breast cancer programme |
14th Jun 2021 7:00 am |
RNS |
Progress with Glioma/Glioblastoma programme |
26th Apr 2021 7:00 am |
RNS |
Appointment of Chief Medical Officer |
7th Apr 2021 7:00 am |
RNS |
Publication on sulforaphane in COVID-19 |
22nd Mar 2021 7:00 am |
RNS |
Appointment of Chief Business Officer |
15th Mar 2021 9:00 am |
RNS |
Holding(s) in Company |
11th Mar 2021 7:00 am |
RNS |
Update on Data Safety Review - STAR COVID-19 trial |
9th Mar 2021 11:35 am |
RNS |
Holding(s) in Company |
8th Mar 2021 1:49 pm |
RNS |
Holding(s) in Company |
5th Mar 2021 4:04 pm |
RNS |
Holding(s) in Company |
5th Mar 2021 9:17 am |
RNS |
Director dealing |
3rd Mar 2021 12:10 pm |
RNS |
Result of General Meeting & Total Voting Rights |
3rd Mar 2021 7:00 am |
RNS |
Result of Open Offer |
26th Feb 2021 4:39 pm |
RNS |
Holding(s) in Company |
17th Feb 2021 9:58 am |
RNS |
Holding(s) in Company |
17th Feb 2021 7:00 am |
RNS |
Update on patient recruitment |
12th Feb 2021 7:00 am |
RNS |
Posting of Circular & Notice of GM |
2nd Feb 2021 3:15 pm |
RNS |
Placing and Open Offer to raise up to £11 million |
22nd Jan 2021 7:00 am |
RNS |
Preclinical data on a new therapeutic target |
21st Jan 2021 7:00 am |
RNS |
Positive pre-clinical data for lead asset SFX-01 |
19th Jan 2021 7:00 am |
RNS |
Patient recruitment update in STAR-COVID 19 trial |
23rd Dec 2020 2:05 pm |
RNS |
Second Price Monitoring Extn |
23rd Dec 2020 2:00 pm |
RNS |
Price Monitoring Extension |
10th Dec 2020 7:00 am |
RNS |
Half-year Report |